The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
A fresh look at tobacco harm reduction: the case for the electronic cigarette
Open accessAbstract
Smokers of any age can reap substantial health benefits by quitting. In fact, no other single public health effort is likely to achieve a benefit comparable to large-scale smoking cessation. Surveys document that most smokers would like to quit, and many have made repeated efforts to do so. However, conventional smoking cessation approaches require nicotine addicted smokers to abstain from tobacco and nicotine entirely. Many smokers are unable--or at least unwilling--to achieve this goal, and so they continue smoking in the face of impending adverse health consequences. In effect, the status quo in smoking cessation presents smokers with just two unpleasant alternatives: quit or suffer the harmful effects of continuing smoking. But, there is a third choice for smokers: tobacco harm reduction. It involves the use of alternative sources of nicotine, including modern smokeless tobacco products like snus and the electronic cigarette (E-cig), or even pharmaceutical nicotine products, as a replacement for smoking. E-cigs might be the most promising product for tobacco harm reduction to date, because, besides delivering nicotine vapour without the combustion products that are responsible for nearly all of smoking's damaging effect, they also replace some of the rituals associated with smoking behaviour. Thus it is likely that smokers who switch to E-cigs will achieve large health gains. The focus of this article is on the health effects of using an E-cig, with consideration given to the acceptability, safety and effectiveness of this product as a long-term substitute for smoking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correspondence - Tranexamic acid for traumatic brain injury
(2005) · London School of Economics and Political Science Theses Online (London School of Economics and Political Science) · doi:10.1016/s0140-6736 · Cited by 11,894
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 1×
“With nearly six million deaths annually, smoking is the single most important cause of avoidable premature mortality in the world [1], mainly from lung cancer, coronary heart disease, chronic obstructive pulmonary disease and stroke [2,3].”
BackgroundShape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414
Effect of smokeless tobacco (snus) on smoking and public health in Sweden
Foulds, J., Ramstrom, L., Burke, M., & Fagerström, K. (2003) · Tobacco Control · doi:10.1136/tc.12.4.349 · Cited by 471
Nicotine Medications for Smoking Cessation
Henningfield, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331807 · Cited by 352
Piasecki, T. M., Fiore, M. C., & Baker, T. B. (1998) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.107.2.238 · Cited by 189
Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials
Mottillo, S., Filion, K. B., Bélisle, P., Joseph, L., Gervais, A., O'Loughlin, J., Paradis, G., Pihl, R., Pilote, L., Rinfret, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn552 · Cited by 171 · cited 1×
“Moreover, the use of pharmaceutical cessation aids [20] and behavioural support [21] have led to limited success in cessation, and it has been argued that the majority of current smokers will continue to smoke”
BackgroundPanel*, N. S.-O.-T.-S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-11-200612050-00141 · Cited by 138
Treatment of nicotine addiction: present therapeutic options and pipeline developments
Polosa, R., & Benowitz, N. L. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.12.008 · Cited by 135 · cited 1×
“Moreover, the use of pharmaceutical cessation aids [20] and behavioural support [21] have led to limited success in cessation, and it has been argued that the majority of current smokers will continue to smoke”
BackgroundTransdermal Nicotine and Haloperidol in Tourette's Disorder: A Double-Blind Placebo-Controlled Study
Silver, A. A., Shytle, D., Philipp, M. K., Wilkinson, B. J., McConville, B., & Sanberg, P. R. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0908 · Cited by 111
Cited by
Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation
Zhu, S.-H., Sun, J. Y., Bonnevie, E., Cummins, S. E., Gamst, A., Yin, L., & Lee, M. (2014) · Tobacco Control · doi:10.1136/tobaccocontrol-2014-051670 · Cited by 913
Farsalinos, K. E., & Polosa, R. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614524430 · Cited by 594
Self-citationHajek, P., Etter, J., Benowitz, N., Eissenberg, T., & McRobbie, H. (2014) · Addiction · doi:10.1111/add.12659 · Cited by 546
Nicotine and the Developing Human
England, L. J., Bunnell, R. E., Pechacek, T. F., Tong, V. T., & McAfee, T. A. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.01.015 · Cited by 320
Farsalinos, K. E., Kistler, K. A., Gillman, G., & Voudris, V. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu176 · Cited by 306
Metadata
- Authors
- Polosa, R., Rodu, B., Caponnetto, P., Maglia, M., & Raciti, C.
- Venue
- Harm Reduction Journal
- Published
- 2013
- Volume
- 10
- Issue
- 1
- Pages
- 19
- ISSN
- 1477-7517 (ISSN-L)
- OpenAlex
- W2133007934
- Cited by
- 202
- References
- 13
- FWCI
- 15.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A fresh look at tobacco harm reduction: the case for the electronic cigarette. https://app.cochat.ai/papers/10.1186/1477-7517-10-19
- The paper
- Polosa, R., Rodu, B., Caponnetto, P., Maglia, M., & Raciti, C. (2013). A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduction Journal. https://doi.org/10.1186/1477-7517-10-19
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.